-

Zoetis Scores 100% on 2021 Corporate Equality Index

Joins the ranks of 767 major U.S. businesses that received top marks in the HRC Foundation’s Annual Assessment of LGBTQ Workplace Equality

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced that it received a score of 100 percent on the Human Rights Campaign Foundation’s 2021 Corporate Equality Index (CEI), the nation’s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ workplace equality. This is the first time Zoetis participated in the CEI and the company’s first external recognition of its dedication to LGBTQ+ individuals.

Strong Policies Promote an LGBTQ+-Friendly Workplace

The high marks scored by Zoetis in the CEI reflect the company’s focus on Diversity, Equity and Inclusion (DE&I), which includes strong policies and programs that promote an LGBTQ+-friendly workplace, including:

  • Enhanced parental leave for all new parents in the U.S., including for adoptions, fathers and same sex partners;
  • A new colleague resource group, Pride at Work (PAW), dedicated to supporting LGBTQ+ colleagues and allies;
  • New U.S. benefits that support colleagues, including enhanced gender transition benefits, surrogacy and adoption benefits; and
  • Internal education programs focused on ensuring an inclusive work environment.

“At Zoetis, our colleagues make the difference and we know their differences make us stronger. We strive to cultivate a workplace where colleagues can bring their true selves to work every day and we are committed to accelerating diversity, equity and inclusion,” said Roxanne Lagano, Executive Vice President and Chief Human Resources Officer and Global Operations. “We are proud of the recent programs and policies implemented to support our LGBTQ+ colleagues and we look forward to continuing to strive to make Zoetis a more inclusive place for our LGBTQ+ colleagues and all colleagues.”

How the CEI Rating Works

The CEI rates employers providing these crucial protections to over 18 million U.S. workers and an additional 17 million abroad. Companies rated in the CEI include Fortune magazine’s 500 largest publicly traded businesses, American Lawyer magazine’s top 200 revenue-grossing law firms (AmLaw 200), and hundreds of publicly and privately held mid- to large-sized businesses.

The programs and policies Zoetis offers align with the CEI’s rating against four central pillars: non-discrimination policies across business entities; equitable benefits for LGBTQ workers and their families; supporting an inclusive culture; and corporate social responsibility.

“We are extremely proud to earn the Best Place to Work for LGBTQ Equality designation from the Human Rights Campaign Foundation,” said Evelyn Ortiz, Chief Talent, Diversity, Equity & Inclusion Officer. “We are committed to creating a workplace that celebrates and elevates the contributions of our LGBTQ+ colleagues in line with our DE&I strategy and in partnership with our Pride at Work (PAW) Colleague Resource Group members, and we will continue to focus on programs, policies and education that provide a supportive and inclusive culture for all of our colleagues.”

Learn More

Learn more about Zoetis’ commitment to Diversity, Equity and Inclusion, including our aspirations for change by 2025, on our website. You may also access the Human Rights Campaign Foundation’s full 2021 report online at www.hrc.org/cei.

About Zoetis

Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees. For more information, visit www.zoetis.com.

About The Human Rights Campaign Foundation

The Human Rights Campaign Foundation is the educational arm of America's largest civil rights organization working to achieve equality for lesbian, gay, bisexual transgender and queer people. HRC envisions a world where LGBTQ people are embraced as full members of society at home, at work and in every community.

ZTS-COR

Contacts

Media:
Kristen Seely
1-973-443-2777 (o)
kristen.seely@zoetis.com

Zoetis Inc.

NYSE:ZTS

Release Summary
Zoetis named a best place to work for LGBTQ equality.
Release Versions
$Cashtags

Contacts

Media:
Kristen Seely
1-973-443-2777 (o)
kristen.seely@zoetis.com

Social Media Profiles
More News From Zoetis Inc.

Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. today announced that Simparica Trio has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the treatment of infestations caused by New World screwworm (Cochliomyia hominivorax) larvae (myiasis) in dogs and puppies. Larvae of Cochliomyia hominivorax, commonly called New World screwworm (NWS), feed on living tissues, such as open wounds, of animals including livestock, wildlife and pets, and can inflict da...

Zoetis Announces Second Quarter 2026 Results

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS), the world's leading animal health company, today reported its financial results for the second quarter of 2026. The company reported revenue of $2.5 billion for the second quarter of 2026, flat compared with the second quarter of 2025, decreasing 1% on an organic operational1 basis. Net income for the second quarter of 2026 was $691 million, or $1.65 per diluted share, decreasing 5% and growing 1%, respectively, on a reported basis. Adj...

Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced the appointment of James (Jay) Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. In this newly created role, Mr. Saccaro will lead Zoetis’ global finance function, shaping capital allocation, financial strategy, reporting and controls, and investor engagement and oversee Global Manufacturing and Supply to drive operational execution and performance. With...
Back to Newsroom